₹172.05
−1.06%NSE close, 16 Nov 2026
+69.09%
QMS Medical Allied Services is a small cap company, listed on NSE under the symbol QMSMEDI. At ₹172.05 a share, the market values the whole company at ₹333 crore.
In FY26, it reported sales of ₹173 crore and a net profit of ₹12 crore, an operating margin of 15.0%. Over the last three years, sales grew 18.4% a year and net profit grew 23.2% a year.
The market values the company at 29.7 times its profit over the last twelve months and 3.66 times its book value; its return on equity is 12.3% and its borrowings are 0.96 times its equity.
Promoters hold 68.11% of the shares. Foreign institutions hold 0.41%, and domestic institutions, mutual funds among them, 1.30%.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | 6M to Mar 2023 S | 6M to Sep 2023 S | 6M to Mar 2024 S | Sep 2024 | 6M to Mar 2025 | Jun 2025 | 6M to Sep 2025 | Dec 2025 |
|---|
Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026 (the 'Unaudited Financial Results'), along with the Limited Review Report.
Schedule of meet
A copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 30, 2026
QMS Medical Allied Services to acquire Beamoptics Scientific a Pune-based diagnostics and Analytical deep-tech company
| 6M to Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 52.1 | 54.6 | 67.5 | 67.6 | 88.5 | 46.5 | 91.2 | 37.3 | 81.7 | 56.9 | 52.5 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 45.3 | 45.1 | 58.7 | 55.5 | 75.1 | – | 77.8 | – | 69.2 | 48.6 | 46.0 |
| Operating profit | 6.8 | 9.6 | 8.8 | 12.1 | 13.3 | – | 13.4 | – | 12.5 | 8.3 | 6.5 |
| Operating margin | 13.0% | 17.5% | 13.0% | 17.9% | 15.1% | – | 14.6% | – | 15.3% | 14.6% | 12.4% |
| Other income | 0.4 | 0.2 | 0.3 | 0.4 | 1.3 | 0.3 | 0.5 | 0.3 | 0.5 | 0.4 | 0.2 |
| Interest | 0.9 | 1.3 | 1.8 | 1.9 | 2.7 | 1.4 | 2.8 | 1.8 | 3.8 | 1.7 | 1.9 |
| Depreciation | 0.7 | 1.7 | 1.8 | 1.6 | 2.2 | – | 1.8 | – | 2.1 | 1.5 | 1.6 |
| Profit before tax | 5.6 | 6.8 | 5.5 | 9.0 | 9.7 | 4.5 | 9.3 | 4.3 | 7.1 | 5.6 | 3.3 |
| Tax | 1.5 | 1.7 | 1.5 | 2.4 | 2.6 | 1.3 | 2.6 | 1.1 | 1.9 | 1.6 | 0.8 |
| Net profit | 4.1 | 5.0 | 4.0 | 6.6 | 7.1 | 6.3 | 6.7 | 3.2 | 5.2 | 3.7 | 2.4 |
| EPS (₹) | 2.30 | 2.81 | 2.23 | 3.27 | 3.51 | 1.64 | 3.32 | 1.24 | 2.11 | 2.05 | 1.26 |
₹ crore, financial years to March.
| Line | FY23 S | FY24 S | FY25 | FY26 |
|---|---|---|---|---|
| Sales | 104 | 122 | 156 | 173 |
| Expenses | 92.7 | 104 | 131 | 147 |
| Operating profit | 11.3 | 18.4 | 25.4 | 25.9 |
| Operating margin | 10.9% | 15.0% | 16.3% | 15.0% |
| Other income | 0.7 | 0.5 | 1.7 | 1.1 |
| Interest | 2.3 | 3.1 | 4.6 | 6.6 |
| Depreciation | 1.1 | 3.4 | 3.8 | 3.9 |
| Profit before tax | 8.7 | 12.2 | 18.7 | 16.4 |
| Tax | 2.3 | 3.2 | 5.0 | 4.5 |
| Net profit | 6.4 | 9.0 | 13.7 | 11.9 |
| EPS (₹) | 3.90 | 5.04 | 6.77 | 5.40 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY23 | FY24 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|---|
| From operations | −7.5 | 1.4 | 20.1 | 19.4 | 3.7 |
| From investing | −25.1 | −2.8 | −45.5 | −20.4 | −11.7 |
| From financing | 31.7 | 0.4 | 25.9 | 1.1 | 7.7 |
| Spent on fixed assets | – | – | 0 | −5.8 | −2.8 |
| Free cash flow | – | – | 20.1 | 13.7 | 0.8 |
Margins, returns, debt, tax and cash.
| Line | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net margin | 6.1% | 7.4% | 8.8% | 6.9% |
| Operating margin | 10.9% | 15.0% | 16.3% | 15.0% |
| Return on equity | – | – | 15.3% | 11.4% |
| Return on capital employed | – | – | 15.5% | 12.9% |
| Return on assets | – | – | 7.2% | 5.6% |
| Debt to equity | – | – | 0.67 | 0.71 |
| Interest coverage | 4.80 | 4.90 | 5.00 | 3.50 |
| Debt to assets | – | – | 0.32 | 0.35 |
| Current ratio | – | – | 1.64 | 1.56 |
| Quick ratio | – | – | 1.10 | 1.05 |
| Cash ratio | – | – | 0.01 | 0.01 |
| Asset turnover | – | – | 0.82 | 0.81 |
| Fixed asset turnover | – | – | 6.78 | 7.55 |
| Inventory turnover | – | – | 2.10 | 2.00 |
| Receivables turnover | – | – | 3.60 | 2.60 |
| Gross margin | – | – | 47.7% | 46.4% |
| Cash from operations to profit | -118.0% | 15.0% | 147.0% | 163.0% |
| Effective tax rate | 26.8% | 26.4% | 26.6% | 27.5% |
HCAH and QMS Join Hands to Create India s Largest Patient Support Program Platform
Outcome of Board Meeting held on September 25, 2026.
QMS Medical Allied Services Completes 100% Acquisition of Saarathi Healthcare Pvt Ltd
Acquisition by additional stake of 24% in Saarathi Healthcare Private Limited, a Subsidiary of the Company. Pursuant to the said acquisition the Company now holds 100% in Saarathi Healthcare Private Limited
General Updates under Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015
Record date for the purpose of Dividend & Meeting is 23-Sep-2026.